JEADV:掌跖脓疱病和Hallopeau连续性肢端皮炎对比研究

2022-04-14 医路坦克 MedSci原创

肢端脓疱型银屑病是一种罕见的致残型银屑病,其有两种临床形式:掌跖脓疱病(PPP)和Hallopeau持续性肢端皮炎(ACH),本文对PPP和ACH的流行病学和临床特征进行比较描述。

肢端脓疱型银屑病是一种罕见的致残型银屑病,在文献中与中年女性和吸烟有关。2017年,欧洲罕见病和重型银屑病专家网络(ERASPEN)区分了两种临床形式:掌跖脓疱病(PPP)和Hallopeau持续性肢端皮炎(ACH)。

一些证据认为PPP有一种特殊的转录和遗传模式,不同于寻常型银屑病(PV)或泛发性脓疱型银屑病(GPP),但ACH和PPP的临床和病理生理特征尚未进行比较。在最近一项报告生物治疗肢端脓疱型银屑病疗效的研究中,我们发现,与PPP患者相比,ACH患者具有特殊的反应特征,用阿达利单抗或依那西普完全清除的比例更高。这些数据将意味着这些疾病是真实的、不同的实体。

很少有数据支持这两种疾病的区别,但还没有研究比较ACH和PPP的临床和流行病学特征。

我们的目的是在多中心回顾队列中对PPP和ACH的流行病学和临床特征进行比较描述。

在这项多中心的国家回顾性队列研究中,我们比较了PPP和ACH患者的流行病学特征、合并症和银屑病特征。

根据2017年ERASPEN标准,共纳入234名患者:203名(87%)患有PPP,18名(8%)患有ACH,13名(6%)同时患有这两种疾病。与ACH相比,PPP与女性性别、吸烟活动和较高的中位数BMI相关(分别为p=0.01、p=0.02和p=0.05)。银屑病的家族背景在PPP组比ACH组更常见。PPP和ACH患者发病年龄相似,中位年龄分别为44岁和48岁。周围关节炎症受累是唯一与ACH相关的风湿性疾病。PPP和ACH与另一种银屑病类型的相关性相似(分别为57.6%和61.1%)。

我们的研究证实,在大量的PPP队列中,女性占优势,吸烟和体重指数升高的发生率很高,但也表明与ACH相比,PPP中的这些特征存在关联。此外,它还强调外周关节炎是与ACH相关的唯一关节炎内型。增加对这两个实体的免疫遗传背景的了解是有必要的,以更好地对脓疱型银屑病或牛皮癣样实体进行分层,以便进行精确医学。

文献来源: Assan F,  Husson B,  Hegazy S,Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographical and clinical comparative study in a large multicentre cohort.J Eur Acad Dermatol Venereol 2022 Apr 02;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1784968, encodeId=03e91e8496803, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Apr 28 17:41:23 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729491, encodeId=92b61e294917a, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 11 17:41:23 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038077, encodeId=8e7320380e742, content=<a href='/topic/show?id=716985205fb' target=_blank style='color:#2F92EE;'>#脓疱病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85205, encryptionId=716985205fb, topicName=脓疱病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 10:41:23 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930256, encodeId=7c2819302567e, content=<a href='/topic/show?id=bb476448d4' target=_blank style='color:#2F92EE;'>#EAU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6448, encryptionId=bb476448d4, topicName=EAU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Thu Oct 06 06:41:23 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329612, encodeId=24de132961225, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 13 13:41:23 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1784968, encodeId=03e91e8496803, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Apr 28 17:41:23 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729491, encodeId=92b61e294917a, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 11 17:41:23 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038077, encodeId=8e7320380e742, content=<a href='/topic/show?id=716985205fb' target=_blank style='color:#2F92EE;'>#脓疱病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85205, encryptionId=716985205fb, topicName=脓疱病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 10:41:23 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930256, encodeId=7c2819302567e, content=<a href='/topic/show?id=bb476448d4' target=_blank style='color:#2F92EE;'>#EAU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6448, encryptionId=bb476448d4, topicName=EAU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Thu Oct 06 06:41:23 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329612, encodeId=24de132961225, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 13 13:41:23 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-08-11 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1784968, encodeId=03e91e8496803, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Apr 28 17:41:23 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729491, encodeId=92b61e294917a, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 11 17:41:23 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038077, encodeId=8e7320380e742, content=<a href='/topic/show?id=716985205fb' target=_blank style='color:#2F92EE;'>#脓疱病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85205, encryptionId=716985205fb, topicName=脓疱病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 10:41:23 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930256, encodeId=7c2819302567e, content=<a href='/topic/show?id=bb476448d4' target=_blank style='color:#2F92EE;'>#EAU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6448, encryptionId=bb476448d4, topicName=EAU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Thu Oct 06 06:41:23 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329612, encodeId=24de132961225, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 13 13:41:23 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1784968, encodeId=03e91e8496803, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Apr 28 17:41:23 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729491, encodeId=92b61e294917a, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 11 17:41:23 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038077, encodeId=8e7320380e742, content=<a href='/topic/show?id=716985205fb' target=_blank style='color:#2F92EE;'>#脓疱病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85205, encryptionId=716985205fb, topicName=脓疱病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 10:41:23 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930256, encodeId=7c2819302567e, content=<a href='/topic/show?id=bb476448d4' target=_blank style='color:#2F92EE;'>#EAU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6448, encryptionId=bb476448d4, topicName=EAU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Thu Oct 06 06:41:23 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329612, encodeId=24de132961225, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 13 13:41:23 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-10-06 839640778
  5. [GetPortalCommentsPageByObjectIdResponse(id=1784968, encodeId=03e91e8496803, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Apr 28 17:41:23 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729491, encodeId=92b61e294917a, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 11 17:41:23 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038077, encodeId=8e7320380e742, content=<a href='/topic/show?id=716985205fb' target=_blank style='color:#2F92EE;'>#脓疱病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85205, encryptionId=716985205fb, topicName=脓疱病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 10:41:23 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930256, encodeId=7c2819302567e, content=<a href='/topic/show?id=bb476448d4' target=_blank style='color:#2F92EE;'>#EAU#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6448, encryptionId=bb476448d4, topicName=EAU)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Thu Oct 06 06:41:23 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329612, encodeId=24de132961225, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Apr 13 13:41:23 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-04-13 膀胱癌

相关资讯

JAMA Dermatol:特应性皮炎的全身免疫调节治疗疗效对比

本文目的是评估中到重度特应性皮炎的系统免疫调节治疗与结果的相关性,包括临床体征、患者报告的症状、皮肤特有的健康相关生活质量和瘙痒严重程度的变化,优先考虑峰值瘙痒数字分级标准。

JAAD:儿童病期白癜风的发病率和特应性皮炎、自身免疫性疾病和银屑病风险的增加相关性研究

儿童期白癜风(COV)被定义为12岁之前发生的白癜风,本文研究分析了COV患者与年龄和性别匹配的健康人相比的发病率和并发疾病的风险,

JAAD:成人特应性皮炎竟会导致注意缺陷多动障碍?

特应性皮炎(AD)是一种慢性炎症性皮肤疾病,与包括注意力缺陷多动障碍(ADHD)在内的各种神经精神疾病的共病有关,本文研究了美国成年人中AD和ADHD之间的联系。

Br J Dermatol:肠道微生物区系竟可以影响银屑病?

越来越多的证据支持自身免疫性疾病与肠道微生物区系改变的关联,肠道微生物区系可能在银屑病等免疫介导性疾病中发挥作用,本文进一步调查肠道微生物对银屑病的影响的关系。

JEADV:患儿和家长对特应性皮炎临床严重程度自我感觉相差多少?

特应性皮炎(AD)是一种对患者及其家庭有强烈影响的慢性疾病,本研究的主要目的是比较受影响的儿童和他们的父母对AD临床严重程度的自我评估。

J Clin Periodontol:牙周炎会影响银屑病吗?

观察性研究表明牙周炎会影响银屑病。然而,观察性研究容易出现反向因果关系和混淆,这阻碍了得出因果关系的结论和影响方向。我们应用孟德尔随机化(MR)方法来全面评估牙周炎和银屑病之间潜在的双向关联。